Ambu A/S

AMBU B

DK0060946788

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-06-18 EDT			5-day change	1st Jan Change
91.65 ^DKK	-2.08%		-9.44%	-11.88%

06-11	DNB Carnegie lowers target price for Ambu to DKK 138 (144), reiterates buy recommendation - BN	FW
05-13	UBS initiates coverage of Ambu with a buy rating and a target price of DKK 147	FW

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Published on 2024-01-30 at 01:00

Ambu A/S maintained earnings guidance for the Full-Year 2023/24. For the period,company expects Organic revenue growth of 7%-10%, EBIT margin before special items of 8%-10%.

Latest news about Ambu A/S

DNB Carnegie lowers target price for Ambu to DKK 138 (144), reiterates buy recommendation - BN	06-11	FW
UBS initiates coverage of Ambu with a buy rating and a target price of DKK 147	05-13	FW
Danske Bank lowers target price for Ambu to DKK 145 (150), reiterates buy recommendation - BN	05-08	FW
DNB lowers target price for Ambu to DKK 144 (155), reiterates buy recommendation - BN	05-08	FW
European shares slip as investors assess earnings, await Fed rate decision	05-07	RE
Ambu A/S, Q2 2025 Earnings Call, May 07, 2025	05-07
Ambu increases sales and operating profit – repeats forecast	05-07	FW
Ambu Q2 Organic Revenue Growth At 11.7%	05-07	RE
Ambu A/S Maintains Financial Guidance for the Year 2024/25	05-07	CI
Ambu A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	05-07	CI
ABG Sundal Collier Upgrades Ambu to Buy, Raises PT	05-06	MT
DNB lowers target price for Ambu to DKK 155 (165), reiterates buy recommendation - BN	05-05	FW
Ambu strengthens Urological Care with new CE Mark expansion	04-23
Danske Bank lowers target price for Ambu to DKK 150 (160), reiterates Buy - BN	04-02	FW
JP Morgan raises target price for Ambu to DKK 90 (76), reiterates neutral - BN	01-31	FW
Ambu A/S, Q1 2025 Earnings Call, Jan 30, 2025	01-30
Ambu increases turnover and net profit	01-30	FW
Ambu A/S Reports Earnings Results for the First Quarter Ended December 31, 2024	01-30	CI
DNB raises target price for Ambu to DKK 165 (140), reiterates Buy - BN	01-22	FW
Ambu A/S Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 08:15 AM	01-15
Svenska Handelsbanken Downgrades Ambu to Underperform, Lifts PT	01-14	MT
Handelsbanken lowers Ambu to underperform (marketperform) in the long term, target price DKK 155 (140)	01-14	FW
ABG Sundal Collier Upgrades Ambu to Hold, Boosts PT	01-13	MT
ABG Sundal Collier upgrades Ambu to Hold (Sell), target price DKK 125 (100) - BN	01-13	FW
SEB raises target price for Ambu to DKK 170 (155), reiterates Buy - BN	01-10	FW

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (59.2%); - emergency care and resuscitation devices (21.4%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (19.4%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2024, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.1%), Europe (38.1%), the United States (49.5%), North America (1.2%) and other (10.1%).

Employees

5,000

Sector

Medical Equipment, Supplies & Distribution

Calendar

08-21 - Q3 2025 Earnings Release

More about the company